Instellingen beheren
MENU
Over deze site
In English
Home
Onderzoekers
Projecten
Organisaties
Publicaties
Infrastructuur
Contact
Research Explorer
Uw browser ondersteunt geen JavaScript of JavaScript is niet ingeschakeld. Zonder JavaScript kan sommige functionaliteit van deze webapplicatie uitgeschakeld zijn of foutmeldingen veroorzaken. Raadpleeg om JavaScript in te schakelen de handleiding van uw browser of contacteer uw systeembeheerder.
Onderzoeker
Bert Vander Cruyssen
Profiel
Projecten
Publicaties
Activiteiten
Prijzen & Erkenningen
71
Resultaten
2018
Etanercept in patients with inflammatory hand osteoarthritis (EHOA) : a multicentre, randomised, double-blind, placebo-controlled trial
Margreet Kloppenburg
Roberta Ramonda
Klaus Bobacz
Wing-Yee Kwok
Dirk Elewaut
Tom WJ Huizinga
Feline PB Kroon
Leonardo Punzi
Josef S Smolen
Bert Vander Cruyssen
et al.
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2018
2012
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis
Martine De Vos
O Dewit
G D'Haens
F Baert
F Fontaine
S Vermeire
D Franchimont
T Moreels
D Staessen
L Terriere
et al.
A1
Artikel in een tijdschrift
in
JOURNAL OF CROHNS & COLITIS
2012
Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis
Ruth Wittoek
Bert Vander Cruyssen
August Verbruggen
A1
Artikel in een tijdschrift
in
ARTHRITIS AND RHEUMATISM
2012
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints : a double blind, randomised trial on structure modification
August Verbruggen
Ruth Wittoek
Bert Vander Cruyssen
Dirk Elewaut
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2012
Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis
Martine De Vos
J Jahnsen
J Vandervoort
G D'haens
O Dewit
E Louis
D Franchimont
F Baert
R Torp
P Potvin
et al.
C3
Conferentie
2012
2011
Microscopic polyangiitis involving the breast
MIEKE DEVINCK
Bert Vander Cruyssen
Kathleen Lambein
Filip De Keyser
Marleen Praet
Guy Brusselle
A1
Artikel in een tijdschrift
in
ACTA CLINICA BELGICA
2011
Optimized alkylated cyclodextrin polysulphates with reduced risks on thromboembolic accidents improve osteoarthritic chondrocyte metabolism
Sara Groeneboer
Stijn Lambrecht
Aad Dhollander
Peggy Jacques
Bert Vander Cruyssen
Rik J Lories
Katrien Devreese
Koen Chiers
Dirk Elewaut
August Verbruggen
A1
Artikel in een tijdschrift
in
RHEUMATOLOGY
2011
Predicting the outcome of ankylosing spondylitis therapy
Nathan Vastesaeger
Désirée van der Heijde
Robert D Inman
Yanxin Wang
Atul Deodhar
Benjamin Hsu
Mahboob U Rahman
Ben Dijkmans
Piet Geusens
Bert Vander Cruyssen
et al.
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2011
2010
Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis
Debby Laukens
Michel Georges
Cécile Libioulle
Cynthia Sandor
Myriam Mni
Bert Vander Cruyssen
Harald Peeters
Dirk Elewaut
Martine De Vos
A1
Artikel in een tijdschrift
in
PLOS ONE
2010
Health status and impact of pain : a comparative study between female patients with the Ehlers-Danlos syndrome, fibromyalgia and rheumatoid arthritis
Lies Rombaut
Fransiska Malfait
STEVEN RIMBAUT
Bert Vander Cruyssen
Anne De Paepe
Patrick Calders
C3
Conferentie
2010
Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery
Bert Vander Cruyssen
Elisa Muñoz-Gomariz
Pilar Font
Juan Mulero
Kurt de Vlam
Annelies Boonen
Janitzia Vazquez-Mellado
Diana Flores
Nathan Vastesaeger
Eduardo Collantes
A1
Artikel in een tijdschrift
in
RHEUMATOLOGY
2010
Morbid anatomy of 'erosive osteoarthritis' of the interphalangeal finger joints : an optimised scoring system to monitor disease progression in affected joints
August Verbruggen
Ruth Wittoek
Bert Vander Cruyssen
Dirk Elewaut
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2010
Reduced levels of the TGFB family member GDF15 in spondyloarthritis versus other rheumatic diseases
Stijn Lambrecht
Filip Van den Bosch
Bert Vander Cruyssen
Filip De Keyser
August Verbruggen
Dieter Deforce
Dirk Elewaut
C3
Conferentie
2010
Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease : attrition rate and evolution of disease activity
Bert Vander Cruyssen
Patrick Durez
Rene Westhovens
Filip De Keyser
A1
Artikel in een tijdschrift
in
ARTHRITIS RESEARCH & THERAPY
2010
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies
Bert Vander Cruyssen
Patrick Durez
Rene Westhovens
Marie-Joelle Kaiser
Ilse Hoffman
Filip De Keyser
A1
Artikel in een tijdschrift
in
ARTHRITIS RESEARCH & THERAPY
2010
2009
Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio products
Ruth Wittoek
Filip De Keyser
A Boonen
Kurt de Vlam
Nathan Vastesaeger
Herman Mielants
Bert Vander Cruyssen
A1
Artikel in een tijdschrift
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2009
Clinical Observations programme in SpA: disease parameters, treatment options and practical management issues
Dirk Elewaut
Filip Van den Bosch
August Verbruggen
Filip De Keyser
Bert Vander Cruyssen
Herman Mielants
A1
Artikel in een tijdschrift
in
Rheumatology International
2009
Cross-cultural adaptation of the Dutch version of the functional index for hand osteoarthritis (FIHOA)and a study on its construct validity
Ruth Wittoek
Bert Vander Cruyssen
E Maheu
August Verbruggen
A1
Artikel in een tijdschrift
in
OSTEOARTHRITIS AND CARTILAGE
2009
Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis
M Georges
Debby Laukens
C Libioulle
C Sandor
M Mni
Bert Vander Cruyssen
Harald Peeters
Dirk Elewaut
Martine De Vos
C3
Conferentie
2009
Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis
Katrien Van Beneden
Ken Coppieters
W Laroy
Filip De Keyser
Ilse Hoffman
Filip Van den Bosch
Bert Vander Cruyssen
Michael Drennan
Peggy Jacques
P Rottiers
et al.
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2009
Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome
Annelies Boonen
Bert Vander Cruyssen
Kurt de Vlam
Serge Steinfeld
Clio Ribbens
Jan Lenaerts
Filip Van den Bosch
Lode Dewulf
Nathan Vastesaeger
A1
Artikel in een tijdschrift
in
JOURNAL OF RHEUMATOLOGY
2009
Validation of a new screening strategy for anti-extractable nuclear antigen antibodies
Jens Van Praet
Bert Vander Cruyssen
Carolien Bonroy
Vanessa Smith
Joris Delanghe
Filip De Keyser
A1
Artikel in een tijdschrift
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2009
2008
A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis
Pieter Dewint
Valerie Gossye
Karolien De Bosscher
Wim Vanden Berghe
Katrien Van Beneden
Dieter Deforce
Serge Van Calenbergh
U MULLER-LADNER
Bert Vander Cruyssen
August Verbruggen
et al.
A1
Artikel in een tijdschrift
in
JOURNAL OF IMMUNOLOGY
2008
Clinical and genetic factors associated with sacroiliitis in Crohn's disease
Harald Peeters
Bert Vander Cruyssen
Herman Mielants
Kurt De Vlam
Severine Vermeire
Edouard Louis
Paul Rurgeerts
Jacques Belaiche
Martine De Vos
A1
Artikel in een tijdschrift
in
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2008
Cyclodextrin polysulphate protects articular cartilage in experimental lapine knee osteoarthritis
Sara Groeneboer
P PASTOUREAU
E VIGNON
Bert Vander Cruyssen
Dirk Elewaut
August Verbruggen
A1
Artikel in een tijdschrift
in
OSTEOARTHRITIS AND CARTILAGE
2008
Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis
Bert Vander Cruyssen
L NOGUEIRA
Jens Van Praet
Dieter Deforce
Dirk Elewaut
G SERRE
Filip De Keyser
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2008
Epidemiology of hip involvement in ankylosing spondylitis
Bert Vander Cruyssen
E MUNOZ-GOMARIZ
P FONT
J MULERO
Kurt De Vlam
A BOONEN
W NOEL
N VASTESAEGER
C3
Conferentie
2008
Over-representation of construction-related occupations in male patients with systemic sclerosis
Vanessa Smith
M. Vanthuyne
Bert Vander Cruyssen
Jens Van Praet
F. Vermeiren
H. Smets
F. Houssiau
Filip De Keyser
A1
Artikel in een tijdschrift
in
Annals of the Rheumatic Diseases
2008
Prediction models for disease: The effect of associations between markers on calculating the risk for disease by likelihood ratio products in SpA
Bert Vander Cruyssen
Ruth Wittoek
A BOONEN
Kurt De Vlam
N VASTESAEGER
W NOEL
Herman Mielants
Filip De Keyser
C3
Conferentie
2008
Reduced metallothionein expression in colonic Crohn's disease: evidence for a new disease-modifying gene
Debby Laukens
Harald Peeters
Anouk Waeytens
Sara Bogaert
Bert Vander Cruyssen
Dirk Elewaut
Filip De Keyser
Herman Mielants
Claude Cuvelier
Kenny Knecht
et al.
C3
Conferentie
2008
Reduced metallothionein expression in colonic Crohn's disease: evidence for it new disease-modifying gene
Debby Laukens
Harald Peeters
Anouk Waeytens
Sara Bogaert
Bert Vander Cruyssen
Dirk Elewaut
Filip De Keyser
Herman Mielants
Claude Cuvelier
P Van Hummelen
et al.
C3
Conferentie
2008
Spontaneous amelioration in early RA: Role of antibody profiles in predicting decrease of disease activity
Bert Vander Cruyssen
AMM MILTENBURG
Filip Van den Bosch
J HOUBIERS
Ruth Wittoek
AMH BOOTS
Filip De Keyser
C3
Conferentie
2008
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
Bert Vander Cruyssen
R WESTHOVENS
P DUREZ
Filip Van den Bosch
Herman Mielants
L DE CLERCK
A PERETZ
M MALAISE
L VERBRUGGEN
L DEWULF
et al.
C3
Conferentie
2008
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
Bert Vander Cruyssen
R WESTHOVENS
P DUREZ
L DE CLERCK
A PERETZ
L VERBRUGGEN
N VASTESAEGER
W NOEL
F DE KEYSER
C3
Conferentie
2008
Validation of a new screening strategy for anti-ENA antibodies
Jens Van Praet
Bert Vander Cruyssen
Carolien Bonroy
Vanessa Smith
Joris Delanghe
Filip De Keyser
C3
Conferentie
2008
Xylosan polysulphate as a symptom modifying osteoarthritis drug in patients with finger joint arthritis
Bert Vander Cruyssen
Q. Moqadam
Sara Groeneboer
D. Cullis-Hill
P. Ghosh
August Verbruggen
C3
Conferentie
2008
2007
A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner
Ken Coppieters
Katrien Van Beneden
Peggy Jacques
Pieter Dewint
Ann Vervloet
Bert Vander Cruyssen
Serge Van Calenbergh
Guangwu Chen
Richard Franck
August Verbruggen
et al.
A1
Artikel in een tijdschrift
in
JOURNAL OF IMMUNOLOGY
2007
Osteochondral repair in synovial joints
August Verbruggen
Ruth Wittoek
Sara Groeneboer
Bert Vander Cruyssen
Stefan Goemaere
Dirk Elewaut
A1
Artikel in een tijdschrift
in
CURRENT OPINION IN RHEUMATOLOGY
2007
Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis
Bert Vander Cruyssen
Lieve Nuytinck
Luc Boullart
Dirk Elewaut
Willem Waegeman
Mira Van Thielen
E. DE MEESTER
K. LEBEER
R. ROSSAU
Filip De Keyser
A1
Artikel in een tijdschrift
in
RHEUMATOLOGY
2007
Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis and may have an added value in prediction models
Bert Vander Cruyssen
Lieve Nuytinck
Filip De Keyser
C3
Conferentie
2007
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice
Bert Vander Cruyssen
Clio Ribbens
Annelies Boonen
Herman Mielants
Kurt De Vlam
Jan Lenaerts
Serge Steinfeld
Filip Van den Bosch
Lode Dewulf
Nathan Vastesaeger
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2007
2006
Altered gut transcriptome in spondyloarthropathy
Debby Laukens
Harald Peeters
Bert Vander Cruyssen
Tom Boonefaes
Dirk Elewaut
Filip De Keyser
Herman Mielants
Claude Cuvelier
Eric Veys
Kenny Knecht
et al.
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2006
Clinical assessment in the spondyloarthropathies, including psoriatic arthritis
Filip Van den Bosch
Bert Vander Cruyssen
Herman Mielants
A1
Artikel in een tijdschrift
in
CURRENT OPINION IN RHEUMATOLOGY
2006
Comparison of the anti-human citrullinated fibrinogen antibodies assayed by ELISA with 2 other ACPA assays: Diagnostic value and agreement between assays
Bert Vander Cruyssen
L NOGUEIRA
Tineke Cantaert
C CAVEL
LEEN DE RYCKE
M SEBAG
Dieter Deforce
Dirk Elewaut
G SERRE
Filip De Keyser
C3
Conferentie
2006
Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays
Bert Vander Cruyssen
Tineke Cantaert
L NOGUEIRA
C CLAVEL
LEEN DE RYCKE
A DENDOVEN
M SEBAG
Dieter Deforce
C VINCENT
Dirk Elewaut
et al.
A1
Artikel in een tijdschrift
in
ARTHRITIS RESEARCH & THERAPY
2006
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition
Bert Vander Cruyssen
R WESTHOVENS
P DUREZ
Filip Van den Bosch
Herman Mielants
L DE CLERCK
A PERETZ
M MALAISE
L VERBRUGGEN
N VASTESAEGER
et al.
C3
Conferentie
2006
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
Bert Vander Cruyssen
Stijn Van Looy
Bart Wyns
R WESTHOVENS
P DUREZ
Filip Van den Bosch
Herman Mielants
L DE CLERCK
A PERETZ
M MALAISE
et al.
A1
Artikel in een tijdschrift
in
ARTHRITIS RESEARCH & THERAPY
2006
Markers and outcome measures in chronic immune mediated artrhritis: from association studies to prediction models.
Bert Vander Cruyssen
F De Keyser
Proefschrift
2006
Modeling the probability for rheumatoid arthritis during diagnostic work-up: How to combine the results of ACPA, RF and HLA-SE testing?
Bert Vander Cruyssen
Ilse Hoffman
Isabelle Peene
Ann Union
Herman Mielants
L MEHEUS
F DE KEYSER
C3
Conferentie
2006
Polymorphisms in the ficolin 1 gene (Fcn1) are associated with susceptibility to the development of rheumatoid arthritis
Bert Vander Cruyssen
Lieve Nuytinck
Filip De Keyser
C3
Conferentie
2006
Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment
Stijn Van Looy
Bert Vander Cruyssen
Jeroen Meeus
Bart Wyns
R WESTHOVENS
P DUREZ
Filip Van den Bosch
N VASTESAEGER
A GELDHOF
Luc Boullart
et al.
A1
Artikel in een tijdschrift
in
ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE
2006
Radiological sacroiliitis in Crohn's disease: A multicenter association study
Harald Peeters
Bert Vander Cruyssen
Herman Mielants
Kurt De Vlam
S VERMEIRE
E LOUIS
P RUTGEERTS
J BELAICHE
Martine De Vos
C3
Conferentie
2006
The diagnostic value of the anti-human citrullinated fibrinogen antibodies by elisa compared to anti-CCP2 antibodies, and their agreement with ACPA detected by 3 other substrates
Bert Vander Cruyssen
L Nogueira
T Cantaert
C Cavel
Lies De Rycke
M Sebag
Dieter Deforce
Dirk Elewaut
G Serre
Filip De Keyser
C3
Conferentie
2006
Which patients with ankylosing spondylitis start anti-TNF-alpha therapy in daily clinical practice?
Bert Vander Cruyssen
Herman Mielants
A BOONEN
J LENAERTS
E LESAFFRE
Kurt De Vlam
C RIBBENS
S STEINFELD
Filip Van den Bosch
N VASTESAEGER
et al.
C3
Conferentie
2006
2005
A plant-derived compound with fully dissociated properties on glucocorticoid receptor-mediated gene regulation
R DEWINT
K DE BOSSCHER
W VANDEN BERGHE
Bert Vander Cruyssen
Eric Veys
G HAEGEMAN
Dirk Elewaut
C3
Conferentie
2005
Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis
Bert Vander Cruyssen
Ilse Hoffman
Hans-Georg Zmierczak
Marthe Van Den Berghe
Elli Kruithof
Leen De Rycke
Herman Mielants
Eric Veys
Dominique Baeten
Filip De Keyser
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2005
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
Bert Vander Cruyssen
Isabelle Peene
Tineke Cantaert
Ilse Hoffman
Leen De Rycke
Eric Veys
Filip De Keyser
A1
Artikel in een tijdschrift
in
AUTOIMMUNITY REVIEWS
2005
CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease
Debby Laukens
Harald Peeters
DENIS MARICHAL
Bert Vander Cruyssen
Herman Mielants
Dirk Elewaut
Pieter Demetter
Claude Cuvelier
M VAN DEN BERGHE
Pieter Rottiers
et al.
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2005
CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients
Bert Vander Cruyssen
Harald Peeters
Ilse Hoffman
Debby Laukens
Paul Coucke
DENIS MARICHAL
Claude Cuvelier
Erik Remaut
Eric Veys
Herman Mielants
et al.
A1
Artikel in een tijdschrift
in
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
2005
Comparing statistics with machine learning models to predict dose increase of infliximab for rheumatoid arthritis patients
Stijn Van Looy
Bert Vander Cruyssen
Bart Wyns
Jeroen Meeus
Filip De Keyser
Luc Boullart
P1
Conferentie
2005
Comparison of Machine Learning models for prediction of dose increase in patients with rheumatoid arthritis
Stijn Van Looy
Jeroen Meeus
Bart Wyns
Bert Vander Cruyssen
Luc Boullart
Filip De Keyser
C1
Conferentie
2005
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
Bert Vander Cruyssen
Stijn Van Looy
Bart Wyns
R WESTHOVENS
P DUREZ
M MALAISE
L VERBRUGGEN
N VASTESAEGER
A GELDHOF
Luc Boullart
et al.
A1
Artikel in een tijdschrift
in
ARTHRITIS RESEARCH & THERAPY
2005
DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy
Bert Vander Cruyssen
Stijn Van Looy
Bart Wyns
R WESTHOVENS
P DUREZ
F VAN DEN BOSH
Eric Veys
Herman Mielants
LISELOTTE DE CLERCK
A PERETZ
et al.
C3
Conferentie
2005
Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients
Bert Vander Cruyssen
Stijn Van Looy
R WESTHOVENS
P DUREZ
Filip Van den Bosch
EM VEYS
L DE CLERCK
A PERETZ
M MALAISE
J DEVOGELAER
et al.
C3
Conferentie
2005
Feature selection in the prediction of Infliximab dose increase
Stijn Van Looy
Jeroen Meeus
Bart Wyns
Bert Vander Cruyssen
Filip De Keyser
Luc Boullart
C1
Conferentie
2005
Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers
Leen De Rycke
Isabelle Peene
Elli Kruithof
Ilse Hoffman
Bert Vander Cruyssen
J JURAS
L NUYTINCK
Eric Veys
Filip De Keyser
C3
Conferentie
2005
Potent anti-inflammatory, fully dissociative compound for glucocorticoid receptor-mediated gene regulation
Pieter Dewint
Karolien De Bosscher
Valerie Gossye
Wim Vanden Berghe
Bert Vander Cruyssen
Eric Veys
Guy Haegeman
Dirk Elewaut
C3
Conferentie
2005
2004
Radiological sacroiliitis is linked with CARD15 gene polymorphisms in patients with Crohn's disease
Bert Vander Cruyssen
Harald Peeters
Debby Laukens
P COUCKE
Herman Mielants
Martine De Vos
Filip De Keyser
C3
Conferentie
2004
Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease
Harald Peeters
Bert Vander Cruyssen
Debby Laukens
Paul Coucke
DENIS MARICHAL
MARTINA VAN DEN BERGHE
Claude Cuvelier
Erik Remaut
Herman Mielants
Filip De Keyser
et al.
A1
Artikel in een tijdschrift
in
ANNALS OF THE RHEUMATIC DISEASES
2004
The presence of CARD15 polymorphisms is linked with higher ASCA titers in Crohn's disease
Harald Peeters
Bert Vander Cruyssen
Debby Laukens
P COUCKE
Ilse Hoffman
Filip De Keyser
Martine De Vos
C3
Conferentie
2004
2003
Crohn's disease patients with CARD15 variants have higher risk of developing axial joint involvement
Martine De Vos
Harald Peeters
Bert Vander Cruyssen
Debby Laukens
Denis Marichal
Marthe Vandenberghe
T Van Oostveldt
Dirk Elewaut
Filip De Keyser
Claude Cuvelier
et al.
C3
Conferentie
2003